Activity of anti-cancer protein kinase inhibitors against Leishmania spp. (Q39428089)

11 September 2017

title

Activity of anti-cancer protein kinase inhibitors against Leishmania spp. (English)

1 reference

11 September 2017

Leishmania

1 reference

Lisa Sanderson

1

1 reference

11 September 2017

Vanessa Yardley

series ordinal

2

1 reference

11 September 2017

Simon L Croft

series ordinal

3

1 reference

11 September 2017

language of work or name

English

0 references

publication date

25 March 2014

1 reference

Journal of Antimicrobial Chemotherapy

11 September 2017

published in

1 reference

11 September 2017

volume

69

1 reference

11 September 2017

issue

7

1 reference

11 September 2017

page(s)

1888-1891

1 reference

Leishmaniasis worldwide and global estimates of its incidence

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

Recent advances in leishmaniasis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

Identification of inhibitors of the Leishmania cdc2-related protein kinase CRK3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

MAPK-directed phosphatases preferentially regulate pro- and anti-inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

Factors underlying sensitivity of cancers to small-molecule kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

A quantitative analysis of kinase inhibitor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

Comparison of four different colorimetric and fluorometric cytotoxicity assays in a zebrafish liver cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

Lapatinib-binding protein kinases in the African trypanosome: identification of cellular targets for kinase-directed chemical scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

Src-family and Syk Kinases in Activating and Inhibitory Pathways in Innate Immune Cells: Signaling Cross Talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU069

21 January 2018

Identifiers

DOI

10.1093/JAC/DKU069

1 reference

11 September 2017

1 reference